Squawk on the Street

CNBC
undefined
Jul 29, 2025 • 3min

Cramer's Morning Take: Novo Nordisk 7/29/25

Jim Cramer and Jeff Marks dive into the recent struggles of a major drugmaker, focusing on lowered forecasts and faltering stock performance. They discuss the fierce competition the company faces and the possibility of a price war to regain market traction. Additionally, they explore the unique advantages of Fidelity Active ETFs and their potential to outperform traditional index funds in volatile markets.
undefined
9 snips
Jul 29, 2025 • 43min

SOTS 2nd Hour: Union Pacific & Norfolk CEOs, AstraZeneca CEO, & Consumer Stock Picks 7/29/25

John Sanmarco, a portfolio manager at Neuberger Berman, shares insights on navigating today's consumer market. The discussion highlights improving consumer confidence amidst mixed signals from major sectors. Sanmarco addresses the impact of new tariffs on retail and pharmaceuticals, and analyzes the challenges faced by beauty retailers like Ulta. Additionally, he delves into the monumental Union Pacific and Norfolk Southern merger, exploring its implications for the freight landscape and operational efficiency in the rail industry.
undefined
23 snips
Jul 29, 2025 • 45min

Railroad Mega-Merger, Boeing CEO Exclusive, CEO Changes at Novo Nordisk and P&G 7/29/25

Kelly Ortberg, CEO of Boeing, shares insights on the company’s recent financial turnaround, highlighting a quarter with reduced losses and positive production updates. The episode discusses the ambitious $72 billion merger between Union Pacific and Norfolk Southern and its implications for the railroad industry. It also covers challenges faced by Novo Nordisk in a competitive pharmaceutical market and examines broader market trends, including Boeing's position in defense spending amid evolving corporate strategies.
undefined
6 snips
Jul 28, 2025 • 3min

Cramer's Morning Take: Cisco & Honeywell 7/28/25

Jim Cramer digs into why the Club is backing Cisco, especially after its recent downgrade and the urgent need to disclose AI revenue. He highlights Cisco's strength in landing big contracts with hyperscale customers. The discussion shifts to Honeywell, driven by strategic investments showcased at the NVIDIA conference. Cramer emphasizes Honeywell's ability to maintain a positive outlook even amidst market headwinds, underlining the importance of savvy business strategies for career advancement.
undefined
Jul 28, 2025 • 43min

SOTS 2nd Hour: EU Trade Deal Details & The Impact on Energy, Alcohol Stocks… Plus: This Week’s Earnings/Fed Playbook 7/28/25

Rebecca Patterson, former chief investment strategist at Bridgewater Associates, dives into the recent trade deal with the EU and its significant impact on energy and alcohol stocks. She discusses misconceptions about tariffs and their linkage to AI investments in the market. The conversation touches on the record highs of the S&P and Nasdaq, the busy earnings season with major reports from tech giants, and the evolving consumer trends in the alcohol industry, highlighting the challenges and opportunities ahead.
undefined
Jul 28, 2025 • 49min

Trade Spotlight: U.S Forges Deal Framework With EU, Begins New Talks With China 7/28/25

The discussion centers around a newly established trade framework between the U.S. and EU, introducing a 15% tariff on most EU goods. Insights are shared on the impact of new trade talks with China and the economic implications for investors. President Trump’s remarks on pharmaceutical tariffs are analyzed in the context of reviving U.S. manufacturing. Additionally, there’s a focus on the mega-cap tech earnings season, especially regarding companies like Tesla and Intel, alongside broader market trends and emerging investment risks.
undefined
7 snips
Jul 25, 2025 • 30min

SOTS 2nd Hour: Apollo’s “No Free Lunch” Warning, Tech Investor Dan Niles, & A Read On Luxury 7/25/25

Investment manager Dan Niles, founder of Niles Investment Management, shares his insights on the tech market trends and warns of possible clouds ahead for major stocks like Apple. He discusses the implications of rising tariffs and the looming threat of stagflation, echoing concerns from Apollo Global's economist. The conversation dives into the dramatic decline of companies like Charter and the challenges facing the luxury retail sector amid shifting consumer behavior. Niles also highlights the resilience and strategies of affluent consumers in today's economy.
undefined
Jul 25, 2025 • 1h 5min

Pres. Trump Visits the Federal Reserve, Righting the Chip, Live: FCC Chairman Carr 7/25/25

In a lively conversation, President Trump shares his recent visit to the Federal Reserve, where he debated renovation costs with Powell while backing off firing threats. Economist Torsten Slok from Apollo Global Management dives into the dollar's dynamics, inflation, and macroeconomic trends affecting trade. They explore the balance between a strong and weaker dollar amidst trade negotiations and geopolitical tensions. The dialogue highlights the urgent need for new trade deals as businesses adapt to a shifting economic landscape.
undefined
6 snips
Jul 24, 2025 • 43min

SOTS 2nd Hour: Alphabet & Tesla Takes, LIVE: CSX CEO, UnitedHealth’s Road Ahead 7/24/25

Jonathan Kanter, a former Assistant Attorney General and CNBC contributor, offers a keen legal perspective on the ongoing DOJ investigation into UnitedHealth. He discusses the implications of the case, alongside insights on potential rail mergers affecting the industry. The podcast also breaks down Alphabet's strong earnings amid antitrust scrutiny and Tesla's future financial challenges, providing an optimistic outlook. With commentary from key CEOs about the evolving market landscape and innovations in AI and transportation, it's a treasure trove of timely insights!
undefined
10 snips
Jul 24, 2025 • 45min

A Tale of Two Tech Earnings, UNH DOJ Investigation, Live: Commerce Secretary Lutnick 7/24/25

Howard Lutnick, the U.S. Commerce Secretary, joins to delve into crucial trade discussions with the EU, emphasizing the urgent need for finalizing a trade deal. The impacts of a significant $550 billion investment between Japan and the U.S. also take center stage. Meanwhile, mixed earnings results are analyzed, highlighting Alphabet's success against Tesla's struggles. Regulatory challenges loom as UnitedHealth faces a DOJ investigation, signaling heightened scrutiny in healthcare billing practices.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app